These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9699729)

  • 1. Activity of 17beta-(N-alkyl/arylformamido) and 17beta-[(N-alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors in the hamster flank organ and ear.
    Chen C; Li X; Singh SM; Labrie F
    J Invest Dermatol; 1998 Aug; 111(2):273-8. PubMed ID: 9699729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth suppression of hamster flank organs by topical application of gamma-linolenic and other fatty acid inhibitors of 5alpha-reductase.
    Liang T; Liao S
    J Invest Dermatol; 1997 Aug; 109(2):152-7. PubMed ID: 9242500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topically applied antiandrogenic compounds on sebaceous glands of hamster ears and flank organs.
    Schröder HG; Ziegler M; Nickisch K; Kaufmann J; el Etreby MF
    J Invest Dermatol; 1989 May; 92(5):769-73. PubMed ID: 2715647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.
    Li X; Singh SM; Labrie F
    J Med Chem; 1995 Mar; 38(7):1158-73. PubMed ID: 7707319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
    Chen C; Belanger A; Labrie F
    Endocrinology; 1996 May; 137(5):1752-7. PubMed ID: 8612511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective induction of apoptosis in the hamster flank sebaceous gland organ by a topical liposome 5-alpha-reductase inhibitor: a treatment strategy for acne.
    Li L; Tang L; Baranov E; Yang M; Amoh Y; Katsuoka K; Hoffman RM
    J Dermatol; 2010 Feb; 37(2):156-62. PubMed ID: 20175850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical anti-androgenicity of a new 4-azasteroid in the hamster.
    Brooks JR; Primka RL; Berman C; Krupa DA; Reynolds GF; Rasmusson GH
    Steroids; 1991 Aug; 56(8):428-33. PubMed ID: 1788861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity.
    Chen C; Puy LA; Simard J; Li X; Singh SM; Labrie F
    J Invest Dermatol; 1995 Nov; 105(5):678-82. PubMed ID: 7594643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.
    Cabeza M; Zambrano A; Heuze I; Carrizales E; Palacios A; Segura T; Valencia N; Bratoeff E
    Steroids; 2009 Oct; 74(10-11):793-802. PubMed ID: 19406144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiandrogenic effects of topical combinations of 5 alpha-reductase and androgen receptor inhibitors in the hamster sebaceous glands.
    Matias JR; Malloy VL; Orentreich N
    J Invest Dermatol; 1988 Nov; 91(5):429-33. PubMed ID: 3171218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid.
    Liao S; Lin J; Dang MT; Zhang H; Kao YH; Fukuchi J; Hiipakka RA
    Arch Dermatol Res; 2001 Apr; 293(4):200-5. PubMed ID: 11380153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiandrogenic effects of topically applied spironolactone on the hamster flank organ.
    Weissmann A; Bowden J; Frank BL; Horwitz SN; Frost P
    Arch Dermatol; 1985 Jan; 121(1):57-62. PubMed ID: 3155605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
    Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
    Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical minoxidil does not act as an antiandrogen in the flank organ of the golden Syrian hamster.
    Nuck BA; Fogelson SL; Lucky AW
    Arch Dermatol; 1987 Jan; 123(1):59-61. PubMed ID: 3800423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro].
    Tolman RL; Sahoo SP; Bakshi RK; Gratale D; Patel G; Patel S; Toney J; Chang B; Harris GS
    J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):303-9. PubMed ID: 9219921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local inhibition of sebaceous gland growth by topically applied RU 58841.
    Matias JR; Gaillard M
    Ann N Y Acad Sci; 1995 Jun; 761():56-65. PubMed ID: 7625751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.
    Park WS; Lee CH; Lee BG; Chang IS
    J Dermatol Sci; 2003 Apr; 31(2):91-8. PubMed ID: 12670719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.